Search research articles
Contact Us
Filters
Showing results (51-60 of 221) with videos related to
Page
of 23
Sort By:
Bulletin Du Cancer
|
October 3, 2008
[Anti-angiogenic treatment in the management of metastatic renal cell carcinoma]
Marie Sire, Hervé Wallerand, Florence Kilkoski, et al.
Health Policy (Amsterdam, Netherlands)
|
January 22, 2022
Development of an evidence-based reference framework for care coordination with a focus on the micro level of integrated care: A mixed method design study combining scoping review of reviews and nominal group technique
Françoise Colombani, Gaëlle Encrenaz, Matthieu Sibé, et al.
AJR. American Journal of Roentgenology
|
December 14, 2016
Is Multiparametric MRI Useful for Differentiating Oncocytomas From Chromophobe Renal Cell Carcinomas?
Chloe Galmiche, Jean-Christophe Bernhard, Mokrane Yacoub, et al.
Bulletin Du Cancer
|
February 4, 2006
[New entities in pathological classification and new therapeutic options in renal cell carcinoma]
Jacques-Olivier Bay, Frédérique Penault-Llorca, Alain Ravaud, et al.
Future Oncology (London, England)
|
June 14, 2017
Pulmonary arterial hypertension due to an intratumoral shunt: an unexpected side effect of sunitinib
Amaury Daste, Marion Laine, Marine Gross-Goupil, et al.
Cancers
|
July 1, 2020
Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis
Reza Elaidi, Letuan Phan, Delphine Borchiellini, et al.
Journal of Surgical Case Reports
|
December 15, 2022
Feasibility of robotic-assisted partial nephrectomy for complete remission of metastatic renal cell carcinoma after long exposure to immune checkpoint inhibitors (UroCCR-106)
Samy Mebroukine, Mokrane Yacoub, Clément Michiels, et al.
Therapeutics and Clinical Risk Management
|
June 9, 2022
An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives
Romain Iaxx, Felix Lefort, Charlotte Domblides, et al.
BMC Cancer
|
May 13, 2017
Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response
Diego Teyssonneau, Amaury Daste, Vincent Dousset, et al.
Bulletin Du Cancer
|
July 1, 2014
[Revision of therapeutic index for targeted treatment in kidney cancer: What if toxicity could predict efficacy?]
Thomas Grellety, Camille Brugères-Chakiba, Axel Chaminade, et al.
Page
of 23
Search research articles
Search
Showing results (51-60 of 221) with videos related to
Sort By:
Page
of 23
Bulletin Du Cancer
|
October 3, 2008
[Anti-angiogenic treatment in the management of metastatic renal cell carcinoma]
Marie Sire, Hervé Wallerand, Florence Kilkoski, et al.
Health Policy (Amsterdam, Netherlands)
|
January 22, 2022
Development of an evidence-based reference framework for care coordination with a focus on the micro level of integrated care: A mixed method design study combining scoping review of reviews and nominal group technique
Françoise Colombani, Gaëlle Encrenaz, Matthieu Sibé, et al.
AJR. American Journal of Roentgenology
|
December 14, 2016
Is Multiparametric MRI Useful for Differentiating Oncocytomas From Chromophobe Renal Cell Carcinomas?
Chloe Galmiche, Jean-Christophe Bernhard, Mokrane Yacoub, et al.
Bulletin Du Cancer
|
February 4, 2006
[New entities in pathological classification and new therapeutic options in renal cell carcinoma]
Jacques-Olivier Bay, Frédérique Penault-Llorca, Alain Ravaud, et al.
Future Oncology (London, England)
|
June 14, 2017
Pulmonary arterial hypertension due to an intratumoral shunt: an unexpected side effect of sunitinib
Amaury Daste, Marion Laine, Marine Gross-Goupil, et al.
Cancers
|
July 1, 2020
Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis
Reza Elaidi, Letuan Phan, Delphine Borchiellini, et al.
Journal of Surgical Case Reports
|
December 15, 2022
Feasibility of robotic-assisted partial nephrectomy for complete remission of metastatic renal cell carcinoma after long exposure to immune checkpoint inhibitors (UroCCR-106)
Samy Mebroukine, Mokrane Yacoub, Clément Michiels, et al.
Therapeutics and Clinical Risk Management
|
June 9, 2022
An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives
Romain Iaxx, Felix Lefort, Charlotte Domblides, et al.
BMC Cancer
|
May 13, 2017
Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response
Diego Teyssonneau, Amaury Daste, Vincent Dousset, et al.
Bulletin Du Cancer
|
July 1, 2014
[Revision of therapeutic index for targeted treatment in kidney cancer: What if toxicity could predict efficacy?]
Thomas Grellety, Camille Brugères-Chakiba, Axel Chaminade, et al.
Page
of 23